TY - JOUR
PY - 2022//
TI - Longitudinal course and predictors of depressive symptoms in atopic dermatitis
JO - Journal of the American Academy of Dermatology
A1 - Gabriel, Sylvie
A1 - Chavda, Rajeev
A1 - Yousaf, Muhammad
A1 - Lei, Donald
A1 - Chatrath, Sheena
A1 - Silverberg, Jonathan I.
SP - 582
EP - 591
VL - 87
IS - 3
N2 - BACKGROUND: Atopic dermatitis (AD) is associated with eczematous lesions, pruritus, pain, and sleep disturbance, which may negatively impact mental health over time.
OBJECTIVE: To determine the predictors and longitudinal course of depressive symptoms in adults with AD.
METHODS: A prospective, dermatology practice-based study was performed (N = 695). AD signs, symptoms, and severity and patient health questionnaire-9 (PHQ-9) were assessed.
RESULTS: At baseline, of the 695 participants, 454 (65.32%) had minimal, 139 (20.00%) had mild, 57 (8.20%) had moderate, 27 (3.88%) had moderately severe, and 8 (2.59%) had severe depression. Most had fluctuating levels of depressive symptoms. Feeling bad, thoughts of self-harm, difficulty concentrating, and slow movement were most persistent. Predictors of persistent depression included older age, non-White race, male sex, public or no insurance, more severe itch, skin pain, facial erythema, nipple eczema, sleep disturbance, and presence of pityriasis alba. LIMITATIONS: Single center study.
CONCLUSION: Depressive symptoms are closely related to and fluctuate with AD severity over time. Improved control of AD signs and symptoms, particularly itch, may secondarily improve mental health.
Language: en
LA - en SN - 0190-9622 UR - http://dx.doi.org/10.1016/j.jaad.2022.04.061 ID - ref1 ER -